Misonix, Inc. (Nasdaq: MSON), a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, has entered into a new, three year, exclusive distribution agreement with Instrumentacion, S.A. based in Bogota, Colombia.
Instrumentacion will sell and distribute the SonaStar® Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone Cutter throughout Colombia.
The agreement includes annual minimum purchase requirements.
Instrumentacion has an excellent reputation for introducing high tech, state-of-the-art medical products to the Colombian market and is well known for their commitment to excellence in customer service.
Instrumentacion will sell and distribute the SonaStar® Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone Cutter throughout Colombia.
The agreement includes annual minimum purchase requirements.
Instrumentacion has an excellent reputation for introducing high tech, state-of-the-art medical products to the Colombian market and is well known for their commitment to excellence in customer service.
Instrumentacion supplies a wide range of specialty medical products to the Colombian market with a focus on head, neck and spine surgery.
The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels.
In addition, OsteoSculpt™ bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures.
It offers the convenience and speed of a power instrument while minimizing the peril associated with rotary sharps.
"Misonix is pleased to add Instrumentacion to our ever-growing presence in Latin America. Their reputation as a quality distributor of medical equipment and devices in Colombia is well established," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.
"Their success in introducing new medical devices, as well as their commitment to customer service, was appealing to Misonix.
The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels.
In addition, OsteoSculpt™ bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures.
It offers the convenience and speed of a power instrument while minimizing the peril associated with rotary sharps.
"Misonix is pleased to add Instrumentacion to our ever-growing presence in Latin America. Their reputation as a quality distributor of medical equipment and devices in Colombia is well established," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.
"Their success in introducing new medical devices, as well as their commitment to customer service, was appealing to Misonix.
We are particularly pleased that they will be selling two of our key products through their distribution network."
About Misonix :
Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment.
Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies.
Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications.
With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.
These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances.
About Misonix :
Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment.
Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies.
Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications.
With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.
These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances.
Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made.
Posts
No comments:
Post a Comment
Thanks for your visit, hope you enjoy the content, we expect to see you again soon.